Oral Cannabidiol for Tobacco Cessation — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
United States
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland Last updated January 2026